Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptors

Ähnliche Einträge

• Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma
  von: Politi, Katerina, et al.
  Veröffentlicht: (2010)
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  von: Pao, William, et al.
  Veröffentlicht: (2004)
• Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
  von: Pao, William, et al.
  Veröffentlicht: (2005)
• ERBB3 Independent Activation of the PI3K Pathway in EGFR Mutant Lung Adenocarcinomas
  von: Song, Xiaoling, et al.
  Veröffentlicht: (2015)
• Neuromedin B receptors regulate EGF receptor tyrosine phosphorylation in lung cancer cells
  von: Moody, Terry W., et al.
  Veröffentlicht: (2010)